tamoxifen and glp 1 Too Good to Be True?' GLP-1s Breast Cancer Survival GLP-1 Receptor Agonists in Breast
Description
Important GLP1-GO is not a medical device and does not diagnose, treat, cure, or prevent any medical condition
Maintain systemic anti-inflammation: Long-acting agents like semaglutide and tirzepatide sustain anti-inflammatory effects that may deprive malignant cells of supportive inflammatory signals
However, there are important considerations that affect how you approach physical activity during this time
FDA has approved dipeptidyl peptidase-4 (DPP-IV) resistant long-acting GLP-1s as injectable drugs for treating patients with type 2 diabetes
The timeline depends on dose, tolerance, nutrition, activity, and follow-up consistency
